Gastrointestinal Manifestations of Coronavirus Disease 2019 across the United States: A Multi-Center Cohort Study

By sjmartinez • July 19, 2022

Patel AP, Sanders TK, Prakash P, Law J, Alvencar S, Choi A, Shah J, Patel K, Srivoleti P, Chauhan K, Weissman S, Holzwanger E, Dhingra R, Nguyen M, Kim D, Sidhu T, Stallwood C, Dickstein A, Parekh N, Altayar O, Ciorba MA, Yu J, Chen LA, Tabibian JH, Limketkai BN. Gastrointestinal Manifestations of Coronavirus Disease 2019 across the United States: A Multi-Center Cohort Study. Gastro Hep Adv. 2022 Jul 19. doi: 10.1016/j.gastha.2022.07.002. Epub ahead of print. PMID: 35874930; PMCID: PMC9293374.

Tags: acquired immunodeficiency syndrome, adjusted odds ratio, AIDS, alanine aminotransferase, ALT, analysis of variance, ANOVA, aOR, aspartate aminotransferase, AST, BMI, body mass index, CI, confidence interval, coronavirus disease 2019, covid-19, Digestive Diseases, gastrointestinal, GI, HIV, human immunodeficiency virus, ICU, Institutional Review Board, Intensive Care Unit, IRB, odds ratio, OR, Publications, SARS-CoV-2, SD, standard deviation, UCLA, United States, University of California Los Angeles, US, WHO, World Health Organization

Hidden Webs and Small Bowel Obstruction: Non-steroidal Anti-inflammatory Drug (NSAID)-Induced Diaphragmatic Strictures

Harmon RL, Cheung N, Dietz R Jr, Chandna S, Fathizadeh P. Hidden Webs and Small Bowel Obstruction: Non-steroidal Anti-inflammatory Drug (NSAID)-Induced Diaphragmatic Strictures. Cureus. 2026[...]

Liver Metabolomic Profiling Reveals Distinct Signatures Between Steatosis and Metabolic Dysfunction-Associated Steatohepatitis

Palomurto S, Flam E, Kaminska D, Virtanen KA, Kärjä V, Käkelä P, Pajukanta P, Eberlé D, Haas JT, Raverdy V, Caiazzo R, Pattou F, Staels[...]

Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease

Sundaresh R, Singh J, Meza J, Saab S, Shetty A. Medications for Alcohol Use Disorder Among Patients With Severe Alcohol-Related Liver Disease. JAMA Netw Open.[...]